As a number of businesses in the diagnostics forecasting industry predict lower earnings from COVID-19 tests this year, Siemens Healthineers is reporting that the company’s sales of COVID-19 rapid antigen tests are expected to nearly double in 2022. According to a new quarterly report from the company, Siemens has already…
Subscribe Membership Required
You must be a Subscribe member to access this content.
Already a member? Log in here
